192 related articles for article (PubMed ID: 16731534)
21. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
22. Hyperbaric oxygen therapy does not potentiate doxorubicin-induced cardiotoxicity in rats.
Karagoz B; Suleymanoglu S; Uzun G; Bilgi O; Aydinoz S; Haholu A; Turken O; Onem Y; Kandemir EG
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):287-92. PubMed ID: 18248515
[TBL] [Abstract][Full Text] [Related]
23. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
Working PK; Newman MS; Sullivan T; Yarrington J
J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
[TBL] [Abstract][Full Text] [Related]
24. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
25. Acute exercise protects against doxorubicin cardiotoxicity.
Wonders KY; Hydock DS; Schneider CM; Hayward R
Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
[TBL] [Abstract][Full Text] [Related]
26. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
Bottone AE; Voest EE; de Beer EL
Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity.
Singh G; Singh AT; Abraham A; Bhat B; Mukherjee A; Verma R; Agarwal SK; Jha S; Mukherjee R; Burman AC
J Ethnopharmacol; 2008 Apr; 117(1):123-9. PubMed ID: 18346858
[TBL] [Abstract][Full Text] [Related]
28. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
29. Validation of the use of long-term indwelling jugular catheters in a rat model of cardiotoxicity.
Wachtman LM; Browning MD; Bedja D; Pin S; Gabrielson KL
J Am Assoc Lab Anim Sci; 2006 Sep; 45(5):55-64. PubMed ID: 16995648
[TBL] [Abstract][Full Text] [Related]
30. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy.
Li L; Takemura G; Li Y; Miyata S; Esaki M; Okada H; Kanamori H; Khai NC; Maruyama R; Ogino A; Minatoguchi S; Fujiwara T; Fujiwara H
Circulation; 2006 Jan; 113(4):535-43. PubMed ID: 16449733
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats.
Xu Y; Tian Y; Wei HJ; Chen J; Dong JF; Zacharek A; Zhang JN
Neuroscience; 2011 May; 181():292-9. PubMed ID: 21376106
[TBL] [Abstract][Full Text] [Related]
32. [Effect of enalaprilat on cardiotoxicity induced by doxorubicin].
Santos JM; Luna Filho B; Simões MJ; Moura OA; Ferreira C; Martinez Filho EE; Bocanegra JA
Arq Bras Cardiol; 1996 Oct; 67(4):237-41. PubMed ID: 9181721
[TBL] [Abstract][Full Text] [Related]
33. Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damage.
Emanuelov AK; Shainberg A; Chepurko Y; Kaplan D; Sagie A; Porat E; Arad M; Hochhauser E
Biochem Pharmacol; 2010 Jan; 79(2):180-7. PubMed ID: 19686702
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
[TBL] [Abstract][Full Text] [Related]
36. Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression.
Neilan TG; Jassal DS; Scully MF; Chen G; Deflandre C; McAllister H; Kay E; Austin SC; Halpern EF; Harmey JH; Fitzgerald DJ
Eur Heart J; 2006 May; 27(10):1251-6. PubMed ID: 16624831
[TBL] [Abstract][Full Text] [Related]
37. Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease.
Honold J; Lehmann R; Heeschen C; Walter DH; Assmus B; Sasaki K; Martin H; Haendeler J; Zeiher AM; Dimmeler S
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2238-43. PubMed ID: 16902165
[TBL] [Abstract][Full Text] [Related]
38. Erythropoietin attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain.
Kumral A; Baskin H; Yesilirmak DC; Ergur BU; Aykan S; Genc S; Genc K; Yilmaz O; Tugyan K; Giray O; Duman N; Ozkan H
Neonatology; 2007; 92(4):269-78. PubMed ID: 17627093
[TBL] [Abstract][Full Text] [Related]
39. Regulation of endothelial progenitor cells by prostaglandin E1 via inhibition of apoptosis.
Gensch C; Clever Y; Werner C; Hanhoun M; Böhm M; Laufs U
J Mol Cell Cardiol; 2007 Mar; 42(3):670-7. PubMed ID: 17291526
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin and its non-erythropoietic derivative: do they ameliorate renal tubulointerstitial injury in ureteral obstruction?
Srisawat N; Manotham K; Eiam-Ong S; Katavetin P; Praditpornsilpa K; Eiam-Ong S
Int J Urol; 2008 Oct; 15(11):1011-7. PubMed ID: 18759748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
